Rankings
▼
Calendar
NXTC Q4 2018 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$35M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6M
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.68
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$22M
Free Cash Flow
$21M
Stock-Based Comp.
$125,000
Balance Sheet
Total Assets
$148M
Total Liabilities
$195M
Stockholders' Equity
-$47M
Cash & Equivalents
$135M
← FY 2018
All Quarters
Q1 2019 →